Trials / Completed
CompletedNCT02524301
Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The place of opioid system in anorexia nervosa (AN) physiopathology is still unclear. Conflicting results were published on cerebral spinal fluid or peripheral levels in anorexia nervosa. However, no data have been reported on opioid cerebral activity. Diprenorphine is a ligand with non-selective binding to opiate receptors µ, κ and δ capable to assess the interaction between endogenous opioids and their receptors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Positron Emission Tomography using [11C]diprenorphine | PET using \[11C\]diprenorphine |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2016-07-28
- Completion
- 2016-07-29
- First posted
- 2015-08-14
- Last updated
- 2018-10-29
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02524301. Inclusion in this directory is not an endorsement.